Dr. Abdulnasir M. AlOtaibi | Johns Hopkins Aramco Healthcare
العربية
Log in to
Dr. Abdulnasir M. AlOtaibi

Dr. Abdulnasir M. AlOtaibi

Professional Title: Consultant in Pediatric and Pediatric Infectious Diseases

Specialty: Infectious Diseases, Pediatric Specialties

Location: Dhahran

Gender: Male

Languages: Arabic, English

Doctor Abdulnasir Alotaibi is a consultant in pediatrics and pediatric infectious disease with over sixteen years of experience in the medical field and a special interest in prevention and management of infectious diseases particularly in children and adolescents with cancer and immunity disorders. Other areas of interest include immunization, management of travel-related infections, community or healthcare associated infections, antibiotic stewardship and patient safety.

Professional Experience

2021-present: Consultant, Pediatric Infectious Diseases, Johns Hopkins Aramco Healthcare (JHAH), Dhahran, Saudi Arabia

2015-2021: Consultant, Pediatric Infectious Diseases, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

Education

2012: The Arab Board Council of Medical Specialization, Riyadh, Saudi Arabia

2011: Saudi Boards in Pediatrics, Saudi Commission for Health Specialties, Riyadh, Saudi Arabia

Sub-specialties

2019: Infectious Diseases Subspecialist Affiliate, The Royal College of Physicians and Surgeons of Canada, Ottawa, Ontario, Canada

2018: Clinical Fellowship in Pediatric Infectious Diseases, The Hospital for Sick Children (SickKids) and The University of Toronto, Toronto, Ontario, Canada

2014: Clinical Fellowship in Pediatric Infectious, Diseases with Honors Degree, Saudi Commission for Health Specialties, Riyadh, Saudi Arabia

Residency

2007-2011: Pediatrics, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia

Medical School

2006: Bachelor of Medicine and Bachelor of Surgery, Um Alqura University, Mecca, Saudi Arabia

Publications

Pediatric appendicitis in times of COVID-19: Think MIS-C

Characteristics and outcomes of (COVID-19) in critically ill pediatric patients admitted to the intensive care unit

Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2

Mendelian Susceptibility to Mycobacterial Disease Caused by a Novel Founder IL12B Mutation in Saudi Arabia

Invasive mucormycosis in chronic granulomatous disease

Log in to MyChart